An implantable wire with an electrode, insulated with non-conductive material except at its ends, which serves as an electrical conductor to transmit pacing impulses from an implanted pulse generator to the heart; it is not intended to conduct defibrillation i
| Company | Devices | Share |
|---|---|---|
| Medtronic, Inc. | 53 | 30% |
| Boston Scientific Corporation | 52 | 29% |
| St. Jude Medical, Inc. | 43 | 24% |
| Biotronik Se & Co. Kg | 27 | 15% |
| Microport Crm Srl | 3 | 2% |
Company = labeler of record on GUDID. 5 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| NVN | Drug eluting permanent right ventricular (RV) or right atria | 229 |
| DTB | permanent pacemaker Electrode | 215 |
| NVY | Permanent defibrillator electrodes | 165 |
| OJX | Drug eluting permanent left ventricular (lv) pacemaker elect | 25 |
| NIK | Defibrillator, automatic implantable cardioverter, with card | 21 |
| LWP | Implantable pulse generator, pacemaker (non-CRT) | 12 |
Use these as the dimensions to specify in a tender line.
No closely related category with 50+ devices.
178 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Endocardial/interventricular septal pacing lead", from 5 companies. The largest labeler is Medtronic, Inc. with 30% of records.
NVN (Drug eluting permanent right ventricular (RV) or right atria), DTB (permanent pacemaker Electrode), NVY (Permanent defibrillator electrodes), OJX (Drug eluting permanent left ventricular (lv) pacemaker elect)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add endocardial/interventricular septal pacing lead to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.